ArticleFrontiers in oncology2025

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy.

Chalette Lambert-Swainston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.